Baricitinib, a Covid-19 Drug from Eli Lilly, Is Expensive And Doesn't Do Much

Retrieved on: 2020-12-04 18:22:30

Tags for this article:

Organic compounds

Chemical compounds

Health sciences

COVID-19 drug development

Click the tags to see associated articles and topics

Baricitinib, a Covid-19 Drug from Eli Lilly, Is Expensive And Doesn't Do Much. View article details on hiswai:

Excerpt

... the Food and Drug Administration to treat a subset of hospitalized Covid-19 patients in combination with another medication, the antiviral <b>remdesivir</b>.

Article found on: www.msn.com

View Original Article